TEM Total Utang marang Modal Tempus AI

Lambang korporat lan logo Tempus AI, Inc. (TEM)

The digital scalability of the Tempus AI, Inc (TEM) AI platform enables the instantaneous monetization of massive datasets. The dynamics of asset leverage confirm this potential, where the value of 3.29 indicates the current leverage ratio. The business relies on insurance payouts, which mitigates macro shocks, while its status as a bold innovator in genomics fuels investor optimism regarding the company's future success.

Utang Agregat marang Modal Tempus Labs (TEM): kanggo periode 15.06.2024 - 28.10.2026

Rincian metrik komprehensif lan analitis Tempus AI (TEM)

- rega lan prakiraan konsensus rega:
Bagan rega tempus.com|TEM - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Kapitalisasi pasar Tempus|TEM - Nilai Perusahaan
- data kapitalisasi buku:
Nilai Akuntansi saben Saham Tempus|TEM - Total Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku tempus.com|TEM - Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Tempus AI, Inc|TEM - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Tempus AI, Inc.|TEM - Gunggung tanggungan utang perusahaan|Utang marang nilai buku Tempus
Analisis komprehensif perusahaan:Tempus Labs, TEM
Produk merek Tempus AI, Inc.

For Tempus AI, Inc (TEM), which is developing an AI platform for precision medicine, the debt-to-equity financial leverage trend reflects the balance between expansion and stability. This metric determines the extent of borrowed funds relative to shareholders' equity. The calculation is based on dividing total liabilities by net assets. A high ratio signals over-leverage risks, while a low ratio indicates a conservative approach. This indicator allows for an assessment of the cost of aggressively scaling the genomic library.

Pesaing wigati

Utang marang Ekuitas Qiagen (QGEN)|Rasio Utang marang Ekuitas Ionis Pharmaceuticals, Inc.|Total Utang marang Modal RGEN|Total Utang marang Modal Avidity Corp RNA|Rasio Total Utang marang Ekuitas CRISPR Therapeutics AG (CRSP)|Utang Agregat marang Modal genedx.com WGS|RARE (Ultragenyx) - Total Utang marang Modal|BEAM: Utang marang Modal|SRPT (Sarepta Therapeutics Inc) - Utang marang Ekuitas|TWST (Twist Bioscience Corp) - Rasio Total Utang marang Ekuitas|Utang marang Ekuitas 10x Genomics, Inc. TXG|Utang Agregat marang Ekuitas intelliatx.com (NTLA)|Rasio Total Utang marang Ekuitas STOK|Total Utang marang Modal BLFS (BioLife Solutions Inc)|Utang marang Ekuitas WVE|MAZE - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas Sionna Therapeutics Inc (SION)|PRME - Rasio Kabeh Utang marang Dana Pribadi|TSHA: Total Utang marang Modal|uniQure NV (QURE) - Total Utang marang Modal|MGTX: Total Utang marang Modal|Koefisien Total Utang marang Modal REGENXBIO Corp (RGNX)|Solid Biosciences Inc. (SLDB) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ocugen.com (OCGN)|Total Utang marang Modal PACB|Benitec Biopharma Inc - Koefisien Total Utang marang Modal|Design Pharma (DSGN) - Utang marang Ekuitas|RCKT - Rasio Utang marang Ekuitas|FDMT (4D Molecular Therapeutics) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Lexeo Therapeutics, Inc.|Korro Bio Inc. (KRRO) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal Editas Medicine Inc|Silence Therapeutics Inc. - Total Utang marang Modal|Utang marang Modal PRQR (proqr.com)|Codexis - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas sangamo.com SGMO|Nautilus Biotechnology Inc (NAUT) - Total Utang marang Modal|MGX: Rasio Utang marang Ekuitas|Utang marang Ekuitas Precision BioSciences, Inc.|Generation Bio (GBIO) - Rasio Utang marang Ekuitas|BOLD (Boundless Bio, Inc.) - Total Utang marang Modal|Total Utang marang Modal Exicure Corp (XCUR)|Rasio Total Utang marang Ekuitas Imunon, Inc.|Utang Agregat marang Modal phiopharma.com (PHIO)|MBIO: Total Utang marang Modal|TransCode Therapeutics Inc. - Utang marang Modal|BNGO: Utang marang Ekuitas|APDN: Rasio Total Utang marang Ekuitas|Utang marang Ekuitas bluebird bio (BLUE)|Utang Agregat marang Ekuitas ImmunoPrecise Antibodies Ltd.|OMGA (Omega) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal OMIC|RGLS (Regulus Therapeutics) - Utang marang Ekuitas|Koefisien Total Utang marang Modal syros.com SYRS|Rasio Total Utang marang Ekuitas Telesis Bio|Rasio Kabeh Utang marang Dana Pribadi TRACON Pharmaceuticals Inc. TCON|Unity Bio - Total Utang marang Modal